chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine given from vial that was left out at room temperature over 12 hours
Age: 34.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site erythema
Clinical narrative: pt call hospital call center reporting redness on his injection site since the day after his Jyunneos vaccintion.  Pt has had some more redness durign the call. Pt advised to monitor and to follow-up with PCP or if needed to evaluated earlier to go to UC/ED.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Legal guardian stated child needed 2nd dose of Moderna vaccine today. Guardian did not have vaccine record with her. Child received the Moderna vaccine. Child was observed for 30 minutes without any signs or symptoms of adverse reactions noted. Guardian advised to take child to nearest emergency department if any adverse symptoms noted.
Age: 51.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered
Clinical narrative: PT WAS GIVEN 0.1CC SQ INSTEAD OF ID
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Arrhythmia, Blood test, Chest discomfort, Computerised tomogram
Clinical narrative: Pulmonary Embolisms: 2 weeks after receiving the 4th shot, I was experiencing shortness of breath and heart arrythmia, and tightness in my chest. I went into the hospital and was diagnosed with Pulmonary Embolisms in all 4 lobes of my lungs, as well as NSTEMI because of them. I had a recent history of arrythmia in the recent years, possibly after starting the vaccines. I had an echocardigram a few months previous because of this, and it was normal.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Magnetic resonance imaging, Pulmonary embolism
Clinical narrative: Pulmonary Embolisms: 2 weeks after receiving the 4th shot, I was experiencing shortness of breath and heart arrythmia, and tightness in my chest. I went into the hospital and was diagnosed with Pulmonary Embolisms in all 4 lobes of my lungs, as well as NSTEMI because of them. I had a recent history of arrythmia in the recent years, possibly after starting the vaccines. I had an echocardigram a few months previous because of this, and it was normal.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given the Monovalent vaccine as a booster instead of the bivalent booster.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond use date
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to patient
Age: 45.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Administration site erythema, Administration site warmth, Diarrhoea, Dizziness, Fatigue
Clinical narrative: Muscle pain Dizziness Nausea Headache Redness at admistration site feels hot and is tender Fatigue Now diarrhea and PCP policy is unless you are established patient they won't connect to nurse line to learn if I should or not take antidiarrheal.
Age: 45.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Headache, Injection site pain, Myalgia, Nausea
Clinical narrative: Muscle pain Dizziness Nausea Headache Redness at admistration site feels hot and is tender Fatigue Now diarrhea and PCP policy is unless you are established patient they won't connect to nurse line to learn if I should or not take antidiarrheal.
Age: 54.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect route of product administration
Clinical narrative: JYNNEOS 0.1CC GIVEN SQ R ARM INSTEAD OF ID
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Provider ordered in error and patient was given the Pfizer/BioNTech monvalent as a booster.  No adverse reactions to the vaccine.    We do not have the Bivalent available yet.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond-use date.
Age: 52.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect route of product administration
Clinical narrative: PT GIVEN 0.1CC SQ INSTEAD OF ID.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Benign prostatic hyperplasia, COVID-19, Chest X-ray abnormal
Clinical narrative: A 76 y.o. male admitted to the hospital on 8/21/2022 for weakness after testing positive for COVID. History of anoxic brain injury from cardiac arrest in 1998 and limited mobility at home. D/C 8/25/2022. Discharge Diagnosis and Associated Hospital Course. Acute hypoxemic respiratory failure -Secondary to COVID. Some chronic lung changes on CT, history of pulmonary sarcoid years ago that has been stable. Also component of general debility and deconditioning.  -Initially hypoxic to 86-87% on RA, currently on 3L NC to maintain O2 sat > 90% but no increased work of breathing.  -Treatment of COVID as below. Incentive spirometer. Wean O2 for goal spO2 88-92%. COVID-19 infection- Presented with: cough, weakness, rhinorrhea- Symptom onset: 8/20- Positive COVID-19: 8/20 on home test and 8/21 - Vaccination status: Vaccinated with Pfizer and boosted x 2 with Pfizer. - CXR on admission showed possible edema and/or bronchitis, but may also be chronic changes (post inflammatory scar and bronchitis noted on prior CT scans)- Oxygen status: 3L- Decadron: Yes. Expected end date 8/29/22- Remdesivir: started 8/21, completed 5 days of treatment. LFT's stable. - DVT prophylaxis:Currently on full anticoagulation- Serial COVID labs ordered: Yes- Case Management/Social Services consulted: Yes; History of PE -Bilateral PE in July 2021 -Continue Eliquis 5 BID -wife reports Dr. recommended he stay on eliquis indefinitely; CAD -With cardiac arrest in 1998. PCI to LAD in Apr 1998. -Continue ASA, statin, BB. Ischemic cardiomyopathy -Prior EF 40-45% but most recent echo 6/30/22 with EF 55% -Continue BB. BPH -Continue bethanechol, finasteride, Flomax. Insomnia -Continue home Remeron and nightly Klonopin. Pulmonary nodules -Follows with Dr.  -Repeat CT chest in May 2022 stable if not improved so pulm recommended repeat CT chest in one year (May 2023).
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Echocardiogram normal, Ejection fraction normal, Insomnia
Clinical narrative: A 76 y.o. male admitted to the hospital on 8/21/2022 for weakness after testing positive for COVID. History of anoxic brain injury from cardiac arrest in 1998 and limited mobility at home. D/C 8/25/2022. Discharge Diagnosis and Associated Hospital Course. Acute hypoxemic respiratory failure -Secondary to COVID. Some chronic lung changes on CT, history of pulmonary sarcoid years ago that has been stable. Also component of general debility and deconditioning.  -Initially hypoxic to 86-87% on RA, currently on 3L NC to maintain O2 sat > 90% but no increased work of breathing.  -Treatment of COVID as below. Incentive spirometer. Wean O2 for goal spO2 88-92%. COVID-19 infection- Presented with: cough, weakness, rhinorrhea- Symptom onset: 8/20- Positive COVID-19: 8/20 on home test and 8/21 - Vaccination status: Vaccinated with Pfizer and boosted x 2 with Pfizer. - CXR on admission showed possible edema and/or bronchitis, but may also be chronic changes (post inflammatory scar and bronchitis noted on prior CT scans)- Oxygen status: 3L- Decadron: Yes. Expected end date 8/29/22- Remdesivir: started 8/21, completed 5 days of treatment. LFT's stable. - DVT prophylaxis:Currently on full anticoagulation- Serial COVID labs ordered: Yes- Case Management/Social Services consulted: Yes; History of PE -Bilateral PE in July 2021 -Continue Eliquis 5 BID -wife reports Dr. recommended he stay on eliquis indefinitely; CAD -With cardiac arrest in 1998. PCI to LAD in Apr 1998. -Continue ASA, statin, BB. Ischemic cardiomyopathy -Prior EF 40-45% but most recent echo 6/30/22 with EF 55% -Continue BB. BPH -Continue bethanechol, finasteride, Flomax. Insomnia -Continue home Remeron and nightly Klonopin. Pulmonary nodules -Follows with Dr.  -Repeat CT chest in May 2022 stable if not improved so pulm recommended repeat CT chest in one year (May 2023).
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Ischaemic cardiomyopathy, Liver function test normal, Physical deconditioning, Pulmonary mass, Rhinorrhoea
Clinical narrative: A 76 y.o. male admitted to the hospital on 8/21/2022 for weakness after testing positive for COVID. History of anoxic brain injury from cardiac arrest in 1998 and limited mobility at home. D/C 8/25/2022. Discharge Diagnosis and Associated Hospital Course. Acute hypoxemic respiratory failure -Secondary to COVID. Some chronic lung changes on CT, history of pulmonary sarcoid years ago that has been stable. Also component of general debility and deconditioning.  -Initially hypoxic to 86-87% on RA, currently on 3L NC to maintain O2 sat > 90% but no increased work of breathing.  -Treatment of COVID as below. Incentive spirometer. Wean O2 for goal spO2 88-92%. COVID-19 infection- Presented with: cough, weakness, rhinorrhea- Symptom onset: 8/20- Positive COVID-19: 8/20 on home test and 8/21 - Vaccination status: Vaccinated with Pfizer and boosted x 2 with Pfizer. - CXR on admission showed possible edema and/or bronchitis, but may also be chronic changes (post inflammatory scar and bronchitis noted on prior CT scans)- Oxygen status: 3L- Decadron: Yes. Expected end date 8/29/22- Remdesivir: started 8/21, completed 5 days of treatment. LFT's stable. - DVT prophylaxis:Currently on full anticoagulation- Serial COVID labs ordered: Yes- Case Management/Social Services consulted: Yes; History of PE -Bilateral PE in July 2021 -Continue Eliquis 5 BID -wife reports Dr. recommended he stay on eliquis indefinitely; CAD -With cardiac arrest in 1998. PCI to LAD in Apr 1998. -Continue ASA, statin, BB. Ischemic cardiomyopathy -Prior EF 40-45% but most recent echo 6/30/22 with EF 55% -Continue BB. BPH -Continue bethanechol, finasteride, Flomax. Insomnia -Continue home Remeron and nightly Klonopin. Pulmonary nodules -Follows with Dr.  -Repeat CT chest in May 2022 stable if not improved so pulm recommended repeat CT chest in one year (May 2023).
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: A 76 y.o. male admitted to the hospital on 8/21/2022 for weakness after testing positive for COVID. History of anoxic brain injury from cardiac arrest in 1998 and limited mobility at home. D/C 8/25/2022. Discharge Diagnosis and Associated Hospital Course. Acute hypoxemic respiratory failure -Secondary to COVID. Some chronic lung changes on CT, history of pulmonary sarcoid years ago that has been stable. Also component of general debility and deconditioning.  -Initially hypoxic to 86-87% on RA, currently on 3L NC to maintain O2 sat > 90% but no increased work of breathing.  -Treatment of COVID as below. Incentive spirometer. Wean O2 for goal spO2 88-92%. COVID-19 infection- Presented with: cough, weakness, rhinorrhea- Symptom onset: 8/20- Positive COVID-19: 8/20 on home test and 8/21 - Vaccination status: Vaccinated with Pfizer and boosted x 2 with Pfizer. - CXR on admission showed possible edema and/or bronchitis, but may also be chronic changes (post inflammatory scar and bronchitis noted on prior CT scans)- Oxygen status: 3L- Decadron: Yes. Expected end date 8/29/22- Remdesivir: started 8/21, completed 5 days of treatment. LFT's stable. - DVT prophylaxis:Currently on full anticoagulation- Serial COVID labs ordered: Yes- Case Management/Social Services consulted: Yes; History of PE -Bilateral PE in July 2021 -Continue Eliquis 5 BID -wife reports Dr. recommended he stay on eliquis indefinitely; CAD -With cardiac arrest in 1998. PCI to LAD in Apr 1998. -Continue ASA, statin, BB. Ischemic cardiomyopathy -Prior EF 40-45% but most recent echo 6/30/22 with EF 55% -Continue BB. BPH -Continue bethanechol, finasteride, Flomax. Insomnia -Continue home Remeron and nightly Klonopin. Pulmonary nodules -Follows with Dr.  -Repeat CT chest in May 2022 stable if not improved so pulm recommended repeat CT chest in one year (May 2023).
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pruritus, Urticaria
Clinical narrative: Itchiness, welt on left eye lid approximately 30 minutes after injection. Welt resolved about an hour later on it's own. No anti-allergy medications taken.
Age: 36.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect route of product administration
Clinical narrative: 0.1CC JYNNEOS VACCINE GIVEN SQ INSTEAD OF ID
Age: 17.0
Sex: F
Vaccine: COVID19-2
Symptoms: Vomiting
Clinical narrative: Vomiting.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received second dose of Pfizer without diluent. PCP will be contacting patients parents to discuss. Unknown if patient had any adverse events and or side effects.
Age: 45.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect route of product administration
Clinical narrative: PT GIVEN 0.1CC JYNNEOS SQ INSTEAD OF ID
Age: 21.0
Sex: M
Vaccine: TDAP
Symptoms: Expired product administered
Clinical narrative: Administered vaccine after expiration date  Patient to be re-vaccinated
Age: 49.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond-use date
Age: 41.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect route of product administration
Clinical narrative: JYNNEOS 0.1CC GIVEN SQ INSTEAD OF ID
Age: 75.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: NO ADVERSE AFFECTS MODERNA BIVALENT NOT AVAILABLE AT THIS TIME , ON BACK ORDER.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond-use date.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received 0.25 mL of the COVID-19 Moderna Bivalent vaccine instead of 0.5 mL as prescribed. Pt refused to come back to clinic to receive other half of dose.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond-use date
Age: 51.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Fatigue, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Red, itchy, painful and swollen area extending approximately two  inches beyond injection site in all directions. Whole-body fatigue and intermittent body chills as well.
Age: 51.0
Sex: F
Vaccine: UNK
Symptoms: Injection site swelling
Clinical narrative: Red, itchy, painful and swollen area extending approximately two  inches beyond injection site in all directions. Whole-body fatigue and intermittent body chills as well.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient had begun the primary series using the Moderna 6 mo-5 year vaccine but on 9/9/22 received the Pfizer 5-11 y vaccine.  No other adverse events.
Age: 47.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Fatigue, Oropharyngeal pain, Orthopoxvirus test positive, Throat lesion
Clinical narrative: Onset date 08/20/2022, patient reported sore throat, lesions on the back of his throat and fatigue. He stated that on 08/22/2022 he seek medical attention from pcp and urgent care. Patient tested + for monkeypox on 08/23/2022. F/U with pcp, recommneded isolation for 21 days, no medication was prescribed as per patient. Phone call to patient 09/13/2022, reports his skin is healed and eas cleared out of isolation from pcp. Patient reports he has no pre existing conditions.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond use date
Age: 23.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Impaired work ability, Nausea
Clinical narrative: Employee experienced dizziness and nausea approximately 15 minutes after the 2nd dose of the series. Employee was unable to work and had to go home due to inability to work.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond-use date.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered beyond-use date
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Eye disorder, Partial seizures, Unresponsive to stimuli
Clinical narrative: Patient had a brief event that is likely a brief motor focal seizure in the middle of the day about ten seconds in front  of the class in reading group eyes deviated was briefly unresponsive no family or personal history of seizures  no other trigger
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chest pain, Discomfort, Gingival pain, Immediate post-injection reaction, Mobility decreased
Clinical narrative: Immediate chest pain followed by neck, Jaw, and lower gum pain. This got progressively worse over 4hrs at which point I was bed-ridden. I took 1 Motrin which may have improved the symptoms. The pain reduced over the next 24hrs with only chest pain for the latter 8hrs. This did not impact breathing and just presented as severe pain or pressure in these areas that progressed when leaning forward or bending over.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in jaw
Clinical narrative: Immediate chest pain followed by neck, Jaw, and lower gum pain. This got progressively worse over 4hrs at which point I was bed-ridden. I took 1 Motrin which may have improved the symptoms. The pain reduced over the next 24hrs with only chest pain for the latter 8hrs. This did not impact breathing and just presented as severe pain or pressure in these areas that progressed when leaning forward or bending over.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Angiocardiogram, Arthralgia, Blood test, COVID-19, Chest pain
Clinical narrative: I had vaccination on 09/09/2021. I had sore arm fatigue axillary tenderness under right arm and chest pain that lasted intermittingly for twelve hours that radiated to shoulder blades. I did take some Ibuprofen. On 01/30/2022 I tested COVID-19 Positive. The chest pain returned with a cough and lasted about 7 days. I saw my PCP on 02/01/2022 due to my chest pain. He prescribed Plaxovid which I did not take due to having some improvement with the exception of the chest pain. It was intermittingly non exertion chest pain. On 03/17/2022 I woke up at 4am and the chest pain woke me up out of sleep and it was intense and constant. I went to PCP who did a cardiac work up. I was diagnosed with Pericarditis on 03/19/2022 and treated by cardiologist.  They prescribed me 04/05/2022 Ibuprofen which was tapered down over time. We did have to extend it at follow up as the chest pain was still present in which we repeated the Ibuprofen and tapered again with Colchicine. It was advised by Cardiologist to hold off on second COVID-19 booster. We will revisit this discussion if there is an uptick in COVID-19 cases and possibly changing to Pfizer.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Echocardiogram, Electrocardiogram normal, Injection site pain, Myocardial necrosis marker normal
Clinical narrative: I had vaccination on 09/09/2021. I had sore arm fatigue axillary tenderness under right arm and chest pain that lasted intermittingly for twelve hours that radiated to shoulder blades. I did take some Ibuprofen. On 01/30/2022 I tested COVID-19 Positive. The chest pain returned with a cough and lasted about 7 days. I saw my PCP on 02/01/2022 due to my chest pain. He prescribed Plaxovid which I did not take due to having some improvement with the exception of the chest pain. It was intermittingly non exertion chest pain. On 03/17/2022 I woke up at 4am and the chest pain woke me up out of sleep and it was intense and constant. I went to PCP who did a cardiac work up. I was diagnosed with Pericarditis on 03/19/2022 and treated by cardiologist.  They prescribed me 04/05/2022 Ibuprofen which was tapered down over time. We did have to extend it at follow up as the chest pain was still present in which we repeated the Ibuprofen and tapered again with Colchicine. It was advised by Cardiologist to hold off on second COVID-19 booster. We will revisit this discussion if there is an uptick in COVID-19 cases and possibly changing to Pfizer.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pericarditis, SARS-CoV-2 test positive, Sleep disorder
Clinical narrative: I had vaccination on 09/09/2021. I had sore arm fatigue axillary tenderness under right arm and chest pain that lasted intermittingly for twelve hours that radiated to shoulder blades. I did take some Ibuprofen. On 01/30/2022 I tested COVID-19 Positive. The chest pain returned with a cough and lasted about 7 days. I saw my PCP on 02/01/2022 due to my chest pain. He prescribed Plaxovid which I did not take due to having some improvement with the exception of the chest pain. It was intermittingly non exertion chest pain. On 03/17/2022 I woke up at 4am and the chest pain woke me up out of sleep and it was intense and constant. I went to PCP who did a cardiac work up. I was diagnosed with Pericarditis on 03/19/2022 and treated by cardiologist.  They prescribed me 04/05/2022 Ibuprofen which was tapered down over time. We did have to extend it at follow up as the chest pain was still present in which we repeated the Ibuprofen and tapered again with Colchicine. It was advised by Cardiologist to hold off on second COVID-19 booster. We will revisit this discussion if there is an uptick in COVID-19 cases and possibly changing to Pfizer.
Age: 37.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Immediate post-injection reaction, Palpitations, Paraesthesia, Tachycardia, Throat tightness
Clinical narrative: Immediately after injection, noted tingling along the left face and chin. Also experienced racing heart rate and sensation of throat tightness. Treated with Benadryl 25mg. Throat tightness and tachycardia resolved. Tingling of the face/jaw persisted for ~12 hours
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Pt had begun the Moderna primary vaccine series(6mo-5y dose)  on 7/27/22 but was inadvertently given the Pfizer vaccine (6mo-4y dose) on day of clinic visit.
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer monovalent booster was administered on 08/31/2022 before the updated information to pause the monovalent vaccine for booster shots was received. Also, on 08/31/2022 an other booster shot of Monovalent Moderna (Batch 011B22A) 3rd shot was given to patient with below details:
Age: 67.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Arthralgia, Diarrhoea, Fatigue, Feeling cold, Feeling hot
Clinical narrative: Uncontrollable shaking, vomiting, diarrhea, chills alternating with feeling hot, joint and muscle aches, fatigue, fast heartbeat, bad headache.  Shaking and vomiting stopped after a couple of hours, other symptoms have persisted for 3 days, but are improving.  This did not happen with previous covid vaccines.  Im wondering if it should not be given with the flu shot.
Age: 67.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Headache, Heart rate increased, Myalgia, Tremor, Vomiting
Clinical narrative: Uncontrollable shaking, vomiting, diarrhea, chills alternating with feeling hot, joint and muscle aches, fatigue, fast heartbeat, bad headache.  Shaking and vomiting stopped after a couple of hours, other symptoms have persisted for 3 days, but are improving.  This did not happen with previous covid vaccines.  Im wondering if it should not be given with the flu shot.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Dry throat, Pyrexia
Clinical narrative: dry throat, low grade fever, minor cough
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Injection site irritation, Laboratory test, Pain, Pain in extremity
Clinical narrative: Patient experience localized irritation at the injection site, followed by tingling and pain in extremities (toes, hand and wrist, tip of tongue) starting a few days after injection.  Patient did not seek out treatment immediately as it was mild.  Pain, tingling, and irritation later progressed to entire extremities (shooting pain in bilateral arms, bilateral legs, and bilateral shoulders) over the course of a few weeks. Patient received cortisone injection and methylprednisolone burst and pain was partially relieved on 9/12/2022
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Patient experience localized irritation at the injection site, followed by tingling and pain in extremities (toes, hand and wrist, tip of tongue) starting a few days after injection.  Patient did not seek out treatment immediately as it was mild.  Pain, tingling, and irritation later progressed to entire extremities (shooting pain in bilateral arms, bilateral legs, and bilateral shoulders) over the course of a few weeks. Patient received cortisone injection and methylprednisolone burst and pain was partially relieved on 9/12/2022
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Duplicate vaccine administered. Booster dose administered on 6/4/2022 and discovered after 4th dose administered on 9/13/2022
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Delirium, Nausea, Pain, Vomiting
Clinical narrative: Delirious , nausea vomiting , weakness, body aches
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood test, Burning sensation, Carpal tunnel syndrome, Hypoaesthesia
Clinical narrative: 2 weeks after receiving my first dose, I woke up in the middle of the night with severe numbness and burning in both arms and hands that was unrelenting.  The led to a dx of bilateral carpel tunnel on 5/21/21.  Symptoms continued to worsen to include severe joint pain, swelling and stiffness, which led to a dx of rheumatoid arthritis on 12/1/21.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Joint stiffness, Joint swelling, Magnetic resonance imaging, Rheumatoid arthritis, Sleep disorder
Clinical narrative: 2 weeks after receiving my first dose, I woke up in the middle of the night with severe numbness and burning in both arms and hands that was unrelenting.  The led to a dx of bilateral carpel tunnel on 5/21/21.  Symptoms continued to worsen to include severe joint pain, swelling and stiffness, which led to a dx of rheumatoid arthritis on 12/1/21.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: X-ray
Clinical narrative: 2 weeks after receiving my first dose, I woke up in the middle of the night with severe numbness and burning in both arms and hands that was unrelenting.  The led to a dx of bilateral carpel tunnel on 5/21/21.  Symptoms continued to worsen to include severe joint pain, swelling and stiffness, which led to a dx of rheumatoid arthritis on 12/1/21.
Age: 68.0
Sex: F
Vaccine: FLU4, PNC20
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: PATIENT PRESENTED WITH REDNESS AND ITCHING AROUND INJECTION SITE
Age: 72.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Pyrexia
Clinical narrative: Patient reported that he developed a high grade fever and had to go to the hospital. He did not give any additional information
Age: 56.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Feeling abnormal, Hypersomnia, Pain
Clinical narrative: I woke up the next morning from when I was vaccinated and I felt like I was hit by a truck. I had body aches all over my body, it hurt to move. I slept all day.
Age: 27.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Heart rate increased, Palpitations
Clinical narrative: I mysteriously have unusually elevated heart rate today. I regularly drink coffee and tea and don't usually get such elevation in heart rate from caffeine. Normally my heart rate is in the low 60s bpm when seated, but today my heart rate is around 80 bpm when seated and I feel the pounding heart beats and slight shortness in breath, which sounds like myocarditis or pericarditis. I kind of wonder if it's related to the vaccine I received yesterday. It doesn't seem severe and doesn't significantly affect normal activities. I'll just rest and see.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 77.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: 1408 Vaccination nurse punctured patient with Moderna Bivalent vaccine syringe, after administering vaccine nurse had notcied leakage out of syringe.
Age: 77.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Device connection issue, No adverse event, Underdose
Clinical narrative: 1408 Vaccination nurse punctured patient with Moderna Bivalent vaccine syringe, after administering vaccine nurse had notcied leakage out of syringe.
Age: 1.33
Sex: M
Vaccine: VARCEL
Symptoms: Urticaria
Clinical narrative: 24 hours after injection hives observed over entire body. Zyrtec did not affect hives. Benadryll 4 hours later did not affect hives.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood test, Burning sensation, Carpal tunnel syndrome, Hypoaesthesia
Clinical narrative: 2 weeks after receiving my first dose, I woke up in the middle of the night with severe numbness and burning in both arms and hands that was unrelenting.  The led to a dx of bilateral carpel tunnel on 5/21/21.  Symptoms continued to worsen to include severe joint pain, swelling and stiffness, which led to a dx of rheumatoid arthritis on 12/1/21.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Joint stiffness, Joint swelling, Magnetic resonance imaging, Rheumatoid arthritis, Sleep disorder
Clinical narrative: 2 weeks after receiving my first dose, I woke up in the middle of the night with severe numbness and burning in both arms and hands that was unrelenting.  The led to a dx of bilateral carpel tunnel on 5/21/21.  Symptoms continued to worsen to include severe joint pain, swelling and stiffness, which led to a dx of rheumatoid arthritis on 12/1/21.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: X-ray
Clinical narrative: 2 weeks after receiving my first dose, I woke up in the middle of the night with severe numbness and burning in both arms and hands that was unrelenting.  The led to a dx of bilateral carpel tunnel on 5/21/21.  Symptoms continued to worsen to include severe joint pain, swelling and stiffness, which led to a dx of rheumatoid arthritis on 12/1/21.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per reporter and Regulatory Authority proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per Agency and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and Agency instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per a Regulatory Authority and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per company and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 65.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Blindness, Gait disturbance, Injection site mass, Pyrexia
Clinical narrative: The injection site formed a large lump the size of my hand, fever of 2.5 degrees above normal, blackened out eyesight and weakness and difficulty walking
Age: 27.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Syncope
Clinical narrative: Pt had a syncopal event.   Vitals: 94/50,77, 18, 100%, T 97.8 -- > 109/65,78,18, 100%, 97.7 Instructed pt to seek medical care if symptoms persist.  Pt stable and released from the vaccination site.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per Agency and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and Agency instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Per client and proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per a Regulatory Authority and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and local authority instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Pt reports being light headed Vitals: 9:45 115/55, 64, 18, 100% -- > 9:52 110/53, 60, 18, 100% pt now denies dizziness 9:55 pt sitting up in bed.  Given juice and crackers 10:05 pt escorted out w/ brother.  Pt is asymptomatic.  Pt stable and released from the vaccination site
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Tinnitus
Clinical narrative: Had mild Tinnitus for many years. Now have severe tinnitus, especially after sleeping.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and  instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: No adverse reaction. Reporting this vaccine given on 8/31/2022 on date that approval was revoked for monovalent boosters. Patient has been informed that she can get the bivalent booster in 2 months. It would be hard to prevent this from happening on the same day as the announcement unless we were able to receive a text alert.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: "Per FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and local authority instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes".
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per MMQC and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA agency instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram cerebral, Bacterial test, Biopsy bone marrow, Blindness, Blood test
Clinical narrative: Production of excessive cerebrospinal fluid, resulting in optic nerve damage and blindness.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: CSF volume increased, Cancer screening, Computerised tomogram, Laboratory test, Magnetic resonance imaging
Clinical narrative: Production of excessive cerebrospinal fluid, resulting in optic nerve damage and blindness.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Optic nerve injury
Clinical narrative: Production of excessive cerebrospinal fluid, resulting in optic nerve damage and blindness.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Chills, Fatigue, Feeling cold, Headache
Clinical narrative: Cold Chills Sunday night. Fever during that night and woke up to be covered in sweat like my fever broke. Extreme tiredness all day yesterday. Joint pain down my entire left side. Headache completely around my head like no other. Fever again yesterday which broke a few hours later.  As of now at 7:08pm on the 13th of September, minor headache and just joint pain in left hip area.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperhidrosis, Pyrexia
Clinical narrative: Cold Chills Sunday night. Fever during that night and woke up to be covered in sweat like my fever broke. Extreme tiredness all day yesterday. Joint pain down my entire left side. Headache completely around my head like no other. Fever again yesterday which broke a few hours later.  As of now at 7:08pm on the 13th of September, minor headache and just joint pain in left hip area.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient had no adverse event. We gave the patient primary pfizer vaccine for the patient's 4th dose and then after that we received an email that the primary pfizer vaccine should not be used for booster shot. We let the patient know that he could get another bivalent booster shot after 10/30/2022.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and  instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per a Regulatory Authority and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per Program and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per Agency and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and Agency instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 29.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Flushing, Hyperhidrosis
Clinical narrative: Pt reported flushing/sweating. Vitals: 115/59, 72, 20 -- > 113/63 Pt given a cold compress.  Pt stable and released from the vaccination site
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 65.0
Sex: M
Vaccine: FLU4
Symptoms: Chills, Influenza like illness, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Patient called the pharmacy 3 days after receiving the vaccine to inform us that he was experiencing an adverse reaction to his flu shot.  He was experiencing chills/fever of 102 and other flu like symptoms but tested negative for covid.  He asked that we report his adverse reaction and he would contact his provider.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per program and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Lethargy, Musculoskeletal stiffness, Pyrexia, Respiratory arrest, Skin warm
Clinical narrative: Spiked a fever, was told not to give medicine unless it reached above 102. We went to sleep and woke up around 1:30 to drink milk and stopped breathing, went completely stiff and would not respond until a few minutes later. Was very lethargic after. Felt extremely hot.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Unresponsive to stimuli
Clinical narrative: Spiked a fever, was told not to give medicine unless it reached above 102. We went to sleep and woke up around 1:30 to drink milk and stopped breathing, went completely stiff and would not respond until a few minutes later. Was very lethargic after. Felt extremely hot.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: "Per FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and agency instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes".
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per Agency and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and Agency instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and  instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per Agency and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and HA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Agitation, Cardiac operation, Chills, Hyperhidrosis, Hypertension
Clinical narrative: patient experienced sweating/chills, followed by increased shaking and agitation overnight. Overnight he experienced excessively high blood pressure (230/110+) eventually requiring heart surgery and stent placement.
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Stent placement, Tremor
Clinical narrative: patient experienced sweating/chills, followed by increased shaking and agitation overnight. Overnight he experienced excessively high blood pressure (230/110+) eventually requiring heart surgery and stent placement.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per MMQC and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per site and proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes".
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per site and proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per MMQC and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per MMQC and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 34.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Pt reported flushing/sweating and dizziness. Vitals: 14:15 110/62, 74,19, T 97.8F -- > 14:25 121/74, 60,18, 98.0F, 100%
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per program and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per MMQC and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and DHA instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: " Per Agency and FDA proclamation of moratorium on use of mRNA monovalent vaccines and as booster doses after 31 AUG 2022, and Agency instruction to enter doses administered as such into VAERS; this report was entered for documentation purposes."
Age: 30.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Cold sweat, Feeling cold, Flushing, Hyperhidrosis, Loss of consciousness
Clinical narrative: Pt had a syncopal event w/ associated flushing/sweating.  Pt was cold and clammy.  LOC x10 seconds.  Pt oriented to self, date, situation. Vitals: 16:59 102/57, 61, 16, 99% -- > 17:04 113/51, 65, 16, 99% -- > 17:09 106/65, 75, 16, 98% -- > 17:35 108/57, 67, 18, 98% Ammonia Inhalant used x3 Pt given juice.  Recommended pt f/u w/ PCP.
Age: 30.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Syncope
Clinical narrative: Pt had a syncopal event w/ associated flushing/sweating.  Pt was cold and clammy.  LOC x10 seconds.  Pt oriented to self, date, situation. Vitals: 16:59 102/57, 61, 16, 99% -- > 17:04 113/51, 65, 16, 99% -- > 17:09 106/65, 75, 16, 98% -- > 17:35 108/57, 67, 18, 98% Ammonia Inhalant used x3 Pt given juice.  Recommended pt f/u w/ PCP.